adalimumab 40 mg/0.8ml
A disease-modifying antirheumatic drug (DMARD) and biologic response modifier. It acts as a targeted TNF-alpha blocker to neutralize the excess inflammatory proteins responsible for joint destruction and skin/gut lining inflammation.
Click to expand
Anti Cancer
adalimumab 40 mg/0.8ml
By HETERO HEALTHCARE LIMITED
MRP ₹23,437
Our Price
₹6,800WHO-GMP
ISO Certified
Trusted Exporter
Secure Supply
Strength
40 MG
Packaging
single-dose pre-filled syringe/pen
Type
Pre-Filled Syringe (PFS)
Shelf Life
24 months (2 years)
A disease-modifying antirheumatic drug (DMARD) and biologic response modifier. It acts as a targeted TNF-alpha blocker to neutralize the excess inflammatory proteins responsible for joint destruction and skin/gut lining inflammation.
Manufacturer Info
NameHETERO HEALTHCARE LIMITED
PrescriptionPrescription
Global Compliance
Our products strictly adhere to International Safety Protocols. 2M Pharmaceuticals ensures 100% genuine supply chain monitoring for all export orders.
Adalimumab 40 MG/0.8ML
₹6,800